These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 567586)

  • 1. The role of the cholinergic system in the development of increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1978 Aug; 50(3):221-30. PubMed ID: 567586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on the role of cholinergic mechanisms in the development of increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1979 Jun; 56(1-2):115-21. PubMed ID: 157281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased antagonist potency of naloxone caused by morphine pretreatment in mice.
    Wong CL; Bentley CA
    Eur J Pharmacol; 1978 Feb; 47(4):415-22. PubMed ID: 564774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cholinergic compounds on the development of morphine tolerance, dependence and increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1980 Jan; 61(2):99-109. PubMed ID: 7188753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary studies on increased naloxone potency and its relationship to morphine tolerance and dependence in mice.
    Wong CL; Wai MK; Roberts MB
    Clin Exp Pharmacol Physiol; 1980; 7(3):305-10. PubMed ID: 7190475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chlorpromazine pretreatment on morphine analgesia and naloxone potency in adrenalectomized mice.
    Wong CL; Wai MK
    Clin Exp Pharmacol Physiol; 1982; 9(6):595-601. PubMed ID: 7166003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chlorpromazine pretreatment on the narcotic antagonistic potency of naloxone in mice.
    Wong CL; Wai MK; Roberts MB
    Clin Exp Pharmacol Physiol; 1982; 9(1):69-75. PubMed ID: 7094435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
    Iorio LC; Deacon MA; Ryan EA
    J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cholinergic systems in the expression of morphine withdrawal.
    Sharif SI; el-Kadi AO
    Neurosci Res; 1996 Jun; 25(2):155-60. PubMed ID: 8829152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholinergic drugs on acute and chronic morphine dependence.
    Padmanabha Pillai N; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):146-54. PubMed ID: 7202346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
    Crain SM; Shen KF
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of quaternary naloxone on the increased naloxone potency induced by morphine.
    Wong CL; Wai MK
    Clin Exp Pharmacol Physiol; 1984; 11(5):467-71. PubMed ID: 6084569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of phenobarbitone pretreatment on the narcotic antagonistic potency of naloxone in mice.
    Wong CL; Roberts MB; Wai MK
    Eur J Pharmacol; 1980 Mar; 62(2-3):219-23. PubMed ID: 7379843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
    Lipman JJ; Spencer PS
    Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.